Therapeutics News

Advanced therapies for the treatment of migraine events could provide more benefits with fewer side effects, according to findings published in the Journal of Neuro-Ophthalmology.

Use of omidenepag isopropyl was just as effective and safe as latanoprost in treating primary open-angle glaucoma in Japanese patients, according to findings published in the American Journal of Ophthalmology.

A concentration of 0.05% atropine stymied the rate of myopia progression in preteen children compared with two other concentrations of the drug, according to findings published in Ophthalmology.

The AAO announced its decision to host this year’s meeting, renamed Academy 2020 At Home, on an online platform.

Results from a phase 2b single-arm, open-label trial that showed use of TP-03 for Demodex blepharitis was safe and well-tolerated after 4 weeks of treatment with persisting effects for at least 90 days.

Recent data showed a greater incidence of ocular surface disease symptoms in patients receiving medical treatment for glaucoma, according to a study published in Clinical Ophthalmology.

Ivermectin-metronidazole combined topical gel therapy successfully treated blepharitis caused by Demodex folliculorum infection, according to study results published in Contact Lens and Anterior Eye.

Dry eye is an increasingly recognized and common condition, and complaints of burning and itchy eyes or impaired vision drive patients to seek relief from their eye care providers.

The use of a multi-dose delivery system for treating glaucoma was highly accepted by patients with decreased visual acuity and dexterity problems, according to a study published in the European Journal of Ophthalmology.

The global market for artificial tears was estimated to be $1,609 million in 2018, and it is expected to continue to grow. With so many people buying and using artificial tears, it merits an assessment of their utility.